fda semaglutide warning news october 2025 ๐จ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA warns consumers not to
Description
however, real-world efficacy and safety studies in Diabetic kidney disease (DKD) are scarce

Retatrutide remains in Phase 3 trials with expected approval in 2026-2027
A handful of these people are using [GLP-1s], and we are seeing amazing results

Weight Loss GLP-1 Comparison Brandon, FL Two of the most effective weight loss medications available, side by side

They work by: Suppressing your appetite Making you feel fuller for longer Slowing down the rate that food leaves your stomach

Be open with your healthcare provider about any changes in your mood or mental state